Abstract

OBJECTIVEThis study investigated the predictive value of rises in IgM class antibodies against double stranded DNA (anti-dsDNA) for ensuing relapses in systemic lupus erythematosus (SLE) in comparison with rises in...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
AB0702 IGG and IGM anti-DSDNA isotypes in patients with systemic lupus erythematosus
H.L Staub ... B Keiserman
Annals of the Rheumatic Diseases | VOL. 71
H.L Staub, et. al.H.L Staub ... B Keiserman
01 Jun 2013
Exposure to ticks and seroprevalence of Borrelia burgdorferi among a healthy young population living in the area of southern Podlasie, Poland.
Maria Kozioł-Montewka ... Anna Pańczuk
Annals of agricultural and environmental medicine : AAEM | VOL. 21
Maria Kozioł-Montewka, et. al.Maria Kozioł-Montewka ... Anna Pańczuk
04 Sep 2014
Frequency of IgG, IgM, and IgA class autoantibodies against 2-oxo-acid dehydrogenase complex in 102 Japanese patients with primary biliary cirrhosis
Isao Matsuo ... Kanae Yamaguchi
Hepatology Research | VOL. 15
Isao Matsuo, et. al.Isao Matsuo ... Kanae Yamaguchi
01 Jul 1999
Laboratory Testing for Hit Antibodies: How Much Class Do We Need?.
John G Kelton ... Jane C Moore
Blood | VOL. 104
John G Kelton, et. al.John G Kelton ... Jane C Moore
16 Nov 2004
View more papers

More From: Annals of the Rheumatic Diseases

Paper Title
Journal
Date
Author
The associations between poorer pain-related health status and increased hospitalisations and excess mortality in patients with rheumatoid arthritis (RA): a prospective cohort analysis using the Australian Rheumatology Association Database (ARAD)
Huai Leng Pisaniello ... Samuel Lawrance Whittle
Annals of the Rheumatic Diseases | VOL. -
Huai Leng Pisaniello, et. al.Huai Leng Pisaniello ... Samuel Lawrance Whittle
29 May 2024
Integrated safety analysis of filgotinib in patients with moderate-to-severe rheumatoid arthritis over a treatment duration of up to 8.3 years
Gerd R Burmester ... Daniel Aletaha
Annals of the Rheumatic Diseases | VOL. -
Gerd R Burmester, et. al.Gerd R Burmester ... Daniel Aletaha
23 May 2024
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
Weijia Wang ... Yong Yuan
Annals of the Rheumatic Diseases | VOL. -
Weijia Wang, et. al.Weijia Wang ... Yong Yuan
22 May 2024
Exploring the effect on primary endpoints in trials testing targeted therapy interventions for rheumatoid arthritis: a meta-epidemiological study on the appropriate use of a core outcome set
Philip Rask Lage-Hansen ... Robin Christensen
Annals of the Rheumatic Diseases | VOL. -
Philip Rask Lage-Hansen, et. al.Philip Rask Lage-Hansen ... Robin Christensen
22 May 2024
View more papers